ITGAM and acute myeloid leukemia: Substantial evidence suggests that MDSCs are expanded in AML and significantly contributes to poor prognosis. Specifically, in C57BL/6 mice engrafted with TIB-49 AML, an expansion of CD11b+Gr11+ MDSCs was observed in both the BM and spleen (135).